PISANTI, Simona
 Distribuzione geografica
Continente #
AS - Asia 5.885
NA - Nord America 2.851
EU - Europa 1.128
SA - Sud America 171
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.049
Nazione #
HK - Hong Kong 4.831
US - Stati Uniti d'America 2.809
CN - Cina 360
SG - Singapore 324
IT - Italia 306
RU - Federazione Russa 201
VN - Vietnam 174
UA - Ucraina 155
BR - Brasile 154
DE - Germania 134
SE - Svezia 96
IE - Irlanda 66
TR - Turchia 61
KR - Corea 55
FI - Finlandia 50
GB - Regno Unito 35
IN - India 28
CZ - Repubblica Ceca 22
CA - Canada 20
PL - Polonia 15
MX - Messico 14
ES - Italia 13
JP - Giappone 12
BD - Bangladesh 9
AR - Argentina 7
AT - Austria 7
ID - Indonesia 6
CH - Svizzera 5
IQ - Iraq 5
BE - Belgio 4
IL - Israele 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CL - Cile 2
EG - Egitto 2
EU - Europa 2
FR - Francia 2
JM - Giamaica 2
NL - Olanda 2
PS - Palestinian Territory 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CR - Costa Rica 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
LY - Libia 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 10.049
Città #
Hong Kong 4.828
Ann Arbor 690
Chandler 339
Woodbridge 249
Princeton 186
Jacksonville 181
Dallas 158
Dong Ket 158
Singapore 137
Ashburn 105
Houston 100
Wilmington 98
Beijing 87
Munich 74
Dublin 66
Salerno 58
Izmir 55
Nanjing 55
Boardman 45
Naples 44
Andover 43
Pellezzano 29
Moscow 27
Los Angeles 23
Brno 22
Shenyang 22
New York 20
Fairfield 18
Shanghai 18
Seoul 15
São Paulo 15
Warsaw 15
Norwalk 14
Mestre 13
Pune 13
Seattle 13
Turku 13
Jiaxing 12
Tokyo 12
Changsha 11
Dearborn 11
Hebei 11
Nanchang 11
Fisciano 9
Helsinki 9
Jinan 9
Zhengzhou 9
Boston 8
Düsseldorf 8
Nürnberg 8
Brooklyn 7
Cambridge 7
Columbus 7
Falls Church 7
London 7
Orem 7
Poplar 7
Rome 7
San Francisco 7
Santa Clara 7
Stockholm 7
The Dalles 7
Brasília 6
Denver 6
Ho Chi Minh City 6
Mexico City 6
Montreal 6
West Jordan 6
Belo Horizonte 5
Bengaluru 5
Chennai 5
Domicella 5
Guangzhou 5
Hanoi 5
Qualiano 5
Redwood City 5
Ankara 4
Bari 4
Betim 4
Brussels 4
Carney 4
Casagiove 4
Catania 4
Lanzhou 4
Milan 4
San Diego 4
San Nicola la Strada 4
Sarno 4
Settimo Milanese 4
Tianjin 4
Warrington 4
Washington 4
Zurich 4
Atlanta 3
Birmingham 3
Bologna 3
Chicago 3
Curitiba 3
Hefei 3
Johannesburg 3
Totale 8.423
Nome #
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.487
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 1.012
The endocannabinoid signaling system in cancer 858
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 481
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 466
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 293
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19 262
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 254
Gene Expression Analysis of Mevalonate Kinase Deficiency Affected Children Identifies Molecular Signatures Related to Hematopoiesis 249
Pharmacological actions of statins: a critical appraisal in the management of cancer. 229
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 197
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 193
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 169
Couroupita guianensis bark decoction: From Amazonian medicine to the UHPLC-HRMS chemical profile and its role in inflammation processes and re-epithelialization 161
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 161
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 156
Anandamide inhibits adhesion and migration of breast cancer cells. 140
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 137
Dental care and dentistry practice in the Medieval Medical School of Salerno 135
Cannabidiol: State of the art and new challenges for therapeutic applications 132
p53 regulates the mevalonate pathway in human glioblastoma multiforme. 130
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 129
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 124
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 118
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 116
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 110
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 110
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 101
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 98
3-hydroxytyrosol promotes angiogenesis in vitro by stimulating endothelial cell migration 95
The basis of the modern medical hygiene in the medieval Medical School of Salerno 91
Cannabinoids and cancer: pros and cons of an antitumour strategy. 88
Ganoderma lucidum ethanol extracts enhance re-epithelialization and prevent keratinocytes from free-radical injury 86
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 85
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 84
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 81
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 80
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 78
Novel prospects of statins as therapeutic agents in cancer 76
The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia 75
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 74
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 73
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 73
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 71
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 69
Psychological Stress and Cancer: New Evidence of An Increasingly Strong Link 69
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 67
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 65
Anticancer Activity and Mechanism of Action of Couroupita guianensis Bark Decoction in Gastric Adenocarcinoma Cancer Cell Line 64
Keratinocytes migration promotion, proliferation induction, and free radical injury prevention by 3-hydroxytirosol 61
Activity of Colocasia esculenta (Taro) Corms against Gastric Adenocarcinoma Cells: Chemical Study and Molecular Characterization 54
Medicinal use of cannabis in Europe: The fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use 51
null 50
β -Lactoglobulin Heptapeptide Reduces Oxidative Stress in Intestinal Epithelial Cells and Angiotensin II-Induced Vasoconstriction on Mouse Mesenteric Arteries by Induction of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Translocation 49
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer". 48
Tumor-Associated Macrophage Status in Cancer Treatment 35
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 30
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 30
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 21
Mangostanin, a Xanthone Derived from Garcinia mangostana Fruit, Exerts Protective and Reparative Effects on Oxidative Damage in Human Keratinocytes 20
Totale 10.201
Categoria #
all - tutte 27.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021387 0 0 0 0 33 24 39 10 41 6 52 182
2021/2022353 2 6 0 10 27 7 2 16 57 41 45 140
2022/2023699 56 69 19 101 87 118 8 74 94 12 38 23
2023/2024326 28 37 18 9 22 52 13 23 9 24 33 58
2024/2025992 44 10 46 65 58 79 207 56 123 35 124 145
2025/20265.506 2.284 1.658 1.251 235 78 0 0 0 0 0 0 0
Totale 10.201